Oakwood Capital Management’s Core Laboratories CLB Stock Holding History

Oakwood Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,380	Closed	-$286K	–	92
2014 Q4	$286K	Sell	2,380 -300	-11%	-$39.4K	0.08%	66
2014 Q3	$392K	Sell	2,680 -426	-14%	-$65.8K	0.11%	63
2014 Q2	$519K	Sell	3,106 -995	-24%	-$177K	0.16%	61
2014 Q1	$814K	Sell	4,101 -800	-16%	-$151K	0.27%	56
2013 Q4	$936K	Sell	4,901 -45	-0.9%	-$8.38K	0.31%	57
2013 Q3	$837K	Sell	4,946 -365	-7%	-$56.7K	0.31%	56
2013 Q2	$805K	Buy	+5,311	New	+$753K	0.32%	56

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Oakwood Capital Management's CLB Position: Q1 2015 in Review

Oakwood Capital Management sold out of Core Laboratories (CLB) in Q1 2015, closing a stake of 2,380 shares — an estimated $286K sold.

Oakwood Capital Management first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $936K in Q4 2013. 347 funds tracked by Wall St. Rank hold CLB as of Q1 2015.

Oakwood Capital Management reported no remaining Core Laboratories position as of Q1 2015 after selling out during the quarter.
Oakwood Capital Management sold 2,380 Core Laboratories shares in Q1 2015, an estimated $286K.
Oakwood Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
Oakwood Capital Management's Core Laboratories position peaked at $936K in Q4 2013.
347 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2015.

Based on Oakwood Capital Management's 13F filing for Q1 2015, filed 13 Apr 2015.